HomePGEN • NASDAQ
add
Precigen Inc
Previous close
$3.89
Day range
$3.62 - $4.00
Year range
$1.11 - $5.47
Market cap
1.30B USD
Avg Volume
5.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 4.56M | 283.61% |
Operating expense | 17.64M | 60.41% |
Net income | -23.50M | -19.14% |
Net profit margin | -514.85 | 68.94% |
Earnings per share | — | — |
EBITDA | -20.53M | 7.01% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 97.86M | -0.05% |
Total assets | 155.50M | 7.05% |
Total liabilities | 134.59M | 71.38% |
Total equity | 20.91M | — |
Shares outstanding | 353.93M | — |
Price to book | 64.83 | — |
Return on assets | -33.15% | — |
Return on capital | -41.78% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -23.50M | -19.14% |
Cash from operations | -23.46M | -184.61% |
Cash from investing | 39.87M | 160.99% |
Cash from financing | -514.00K | -100.66% |
Net change in cash | 15.91M | 232.05% |
Free cash flow | -15.52M | -55.18% |
About
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Founded
May 21, 1998
Website
Employees
160
